Trial intelligence / Profile preview

Amlodipine oral liquid versus tablet pharmacokinetic crossover study in healthy adults

NL-OMON36940Phase 4Active, not recruiting

Sponsor
Erasmus MC
Start
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of amlodipine in hypertension (HTN) (2 arms), sponsored by Erasmus MC. Primary endpoints: Cmax, tmax and 2 more. Started Mar 2013; status: active, not recruiting.

02

Drugs

amlodipine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NL-OMON36940.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON36940.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call